On January 3, 2018 Emergent BioSolutions Inc. (NYSE:EBS) reported that a member of the company’s senior management team will participate in the following investor conferences during the first quarter of 2018 (Press release, Emergent BioSolutions, JAN 3, 2018, View Source;p=RssLanding&cat=news&id=2324588 [SID1234522827]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
J.P. Morgan & Co. – 36th Annual Healthcare Conference
San Francisco, CA
January 8-11, 2018
RBC Capital Markets – 2018 Global Healthcare Conference
New York, NY
February 21-22, 2018
Cowen & Co. – 38th Annual Health Care Conference
Boston, MA
March 12-14, 2018
Presentation dates and times will be updated on the Emergent website www.emergentbiosolutions.com under "Investors" as the information becomes available.
For these conferences, the company will be webcasting its presentation, which may include a discussion of the company’s recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website.